Abstract
Stenotrophomonas (Xanthomonas) maltophilia has emerged as a causative agent of serious nosocomial infections. However, well-documented cases of urinary tract infection with this organism have rarely been reported. review of the medical records of patients admitted to a large cancer center with cultures yielding S maltophilia from urinary sources during a 15-month period. All urinary tract infections were serious: 13 were complicated and two were acute uncomplicated pyelonephritis. The urinary tracts of 13 other patients were colonized with S maltophilia. Most of the colonized and infected patients were hospitalized with genitourinary malignancy, underwent urinary catheterization, and were receiving antibiotics inactive against S maltophilia. Neutropenia and urinary structural abnormalities were significantly associated with infection. The clinical course of infection was usually severe: fever (100%), sepsis disorder (47%), neutrophilia (70% of patients without neutropenia), bacteremia (13%) and death (7%). Still, response to treatment was prompt. Stenotrophomonas maltophilia urinary tract infection is usually associated with a severe clinical course. Risk factors for urinary colonization by this organism include hospitalization...Continue Reading
Citations
Apr 19, 2007·Archives of Microbiology·Chiy-Rong ChenShu-Fen Weng
Jan 4, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G AisenbergA Safdar
Mar 6, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A C Nicodemo, J I Garcia Paez
Feb 19, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M E FalagasG Dimopoulos
Oct 15, 2003·Burns : Journal of the International Society for Burn Injuries·Maria DalamagaIlias Migdalis
Nov 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C A SattlerS L Kaplan
Jan 14, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Anna RiberaJordi Vila
Oct 24, 2002·British Journal of Anaesthesia·P-G ChassotD R Spahn
Jan 20, 2000·Antimicrobial Agents and Chemotherapy·L ZhangK Poole
Jun 20, 2000·Antimicrobial Agents and Chemotherapy·A AlonsoJ L Martínez
Jun 28, 2005·Antimicrobial Agents and Chemotherapy·María Dolores Navarro-MartínezJosé Neptuno Rodríguez-López
Mar 5, 2005·Applied and Environmental Microbiology·Hsiao-Chuan ChangShu-Fen Weng
Jan 11, 2012·Clinical Microbiology Reviews·Joanna S Brooke
Aug 9, 2003·Journal of Clinical Microbiology·Chiranjoy MukhopadhyayArchana Ayyagari
Aug 24, 2012·Virology Journal·Dongjun HouJuan Pu
Feb 19, 2014·Annals of Hematology·Minako MoriTakayuki Takahashi
Jan 30, 2014·BMC Microbiology·Chia-Ni LeeShu-Fen Weng
Jun 15, 2010·FEBS Letters·Nopporn ThasanaSuvit Loprasert
Oct 9, 2012·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Ya-Ting ChangYen-Hsu Chen
Apr 13, 2012·The Journal of Hospital Infection·M GaraziC C Ginocchio
Apr 14, 2004·Journal of Applied Microbiology·L H TravassosE A Marques
Nov 7, 2014·PloS One·Go HottaSatoshi Ichiyama
Dec 9, 2014·PloS One·Vanessa NienhouseKatherine A Radek